Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

The Effect of vırtual realıty on paın and Sleep qualıty ın Women

3 juin 2026 mis à jour par: Remzi KARASUNGUR, Hasan Kalyoncu University

The Effect of vıdeo Watched wıth musıc Through vırtual realıty Glasses and musıc lıstenıng Alone on paın and Sleep qualıty ın Women wıth Dysmenorrhea

The aim of this study is to determine whether a video viewed through virtual reality goggles accompanied by music has an effect on pain and sleep quality in women with dysmenorrhea. The main questions it seeks to answer are as follows:

  • Does watching a video through virtual reality goggles accompanied by music reduce pain in women with dysmenorrhea?
  • Does watching a video through virtual reality goggles accompanied by music improve sleep quality in women with dysmenorrhea? The study will compare a group that uses music from the virtual reality video with another group to determine whether the virtual reality application has an effect on pain and sleep quality.

Participants will do the following:

For 3 days, use the virtual reality or music application every evening before going to bed after completing the VAS. The next day, after waking up, complete the VAS and the sleep quality scale and record the results.

Aperçu de l'étude

Statut

Complété

Les conditions

Intervention / Traitement

Type d'étude

Interventionnel

Inscription (Réel)

77

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Baykan
      • Siirt, Baykan, Turquie (Türkiye), 56460
        • Baykan State Hospital

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Enfant
  • Adulte

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • Women who volunteered to participate in the study,
  • Who are at least literate,
  • Aged 15-49 and not yet in menopause,
  • Who are not pregnant,
  • Who have been diagnosed with dysmenorrhea by a physician and have a pain intensity of at least 4 on the Visual Analogue Scale

Exclusion Criteria:

  • Women with dysmenorrhea pain intensity below 4 on the Visual Analog Scale,
  • Women with vision or hearing impairments,
  • Women who are unwilling to participate in the study,
  • Women using analgesic medications for menstrual pain,
  • Pregnant women

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Soins de soutien
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Quadruple

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: experiment
Group shown a video using a virtual reality headset: For this experiment, a video featuring nature scenes and waterfalls was downloaded to a phone, loaded into a virtual reality headset, and provided to the participant ready for use.

Group shown a video using a virtual reality headset: A video containing images of nature and waterfalls is downloaded to a phone and provided to the participant ready to use inside a virtual reality headset; the procedure is carried out as described below.

For three consecutive days, each day:

  • After menstruation begins, apply the VAS pain scale before going to bed in the evening
  • In the evening, in a dark and quiet environment, watch the 30-minute virtual reality video as instructed by the researcher until falling asleep
  • The following morning, apply the VAS pain scale and RCUÖ and inform the researcher.

After the study was completed, the equipment returned to the researcher was calibrated and cleaned as necessary by the researcher and prepared for use with another patient.

Autres noms:
  • Réalité virtuelle
Comparateur placebo: control
Unlike the intervention group, the women in the control group were given MP3 players by the researcher, instructed on how to use them, and had the music used in the virtual reality video loaded onto the devices for them to listen to.

Unlike the intervention group, the women in the control group were given an MP3 player by the researcher, instructed on how to use it, and had the music used in the virtual reality video loaded onto it for them to listen to.

For three consecutive days, each day:

  • Apply the VAS pain scale in the evening before going to bed after menstruation has occurred
  • Listen to the 30-minute music in a dark and quiet environment in the evening, as instructed by the researcher
  • Apply the VAS pain scale and RCUÖ the following morning and inform the researcher.

After the study was completed, the equipment returned to the researcher was calibrated and cleaned as necessary by the researcher and prepared for use with another patient.

Autres noms:
  • musique

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Distribution of women according to the characteristics of their menstrual cycles
Délai: 4 weeks
This table includes the latest menstrual pain scale, the occurrence of pain during the menstrual cycle, the type of dysmenorrhea, the timing of dysmenorrhea, information about menstruation, who provided information about menstruation, the use of pain relievers during the menstrual period, non-pharmacological interventions used to alleviate menstrual pain, non-pharmacological interventions used to alleviate menstrual pain, the presence of dysmenorrhea in the family, and gynecological diagnosis data. Patients with a pain scale (VAS) score of 4 or higher were evaluated, and the analysis proceeded to secondary outcomes.
4 weeks

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Comparison of Participants' Sociodemographic Characteristics by Group
Délai: 2 weeks
This table presents sociodemographic data such as women's marital status, age, and chronic conditions.
2 weeks
A Comparison of Certain Characteristics of Participants' Menstrual Cycles Across Groups
Délai: 4 weeks
This table presents data such as the age at first menstruation, menstrual cycle length, and duration of menstrual bleeding
4 weeks
Comparison of Dysmenorrhea Characteristics Among Participants by Group
Délai: 4 weeks
This table examines data such as the onset of dysmenorrhea, the presence of dysmenorrhea in the family, the family history of dysmenorrhea, the severity of pain during menstruation, and the use of pain relievers during menstruation.
4 weeks
Comparison of Participants' Sleep-Related Characteristics by Group
Délai: 4 weeks
This table provides information on a woman's sleep patterns during her menstrual cycle
4 weeks
Comparisons of Participants' Visual Analog Scale (VAS) Scores Between and Within Groups
Délai: 6 weeks

A visual analog scale is a pain assessment tool where individuals mark their pain level on a horizontal bar ranging from 0 to 10. The starting point of the scale indicates the absence of pain, while the end point indicates that the pain is unbearable.

This table shows the woman's pain scale assessment.

6 weeks
Comparisons of Participants' Richard Campbell Sleep Scale (RCSQ) Scores Across and Within Groups
Délai: 6 weeks
The Richard Campbell Sleep Scale assesses the depth of sleep, the time it takes to fall asleep, the frequency of waking, the duration of wakefulness upon waking, the quality of sleep, and the noise level in the environment. Each item on the scale is scored on a scale of 0 to 100. A score of "0-25" indicates "very poor sleep," while a score of "76-100" indicates "very good sleep." When calculating the total scale score, the scores from the 5 items are added together; the noise level in the environment is not included in the total score calculation.
6 weeks

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Directeur d'études: Remzi KARASUNGUR, not affiliated

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

5 janvier 2023

Achèvement primaire (Réel)

29 mars 2023

Achèvement de l'étude (Réel)

24 septembre 2023

Dates d'inscription aux études

Première soumission

7 avril 2026

Première soumission répondant aux critères de contrôle qualité

3 juin 2026

Première publication (Réel)

8 juin 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

8 juin 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

3 juin 2026

Dernière vérification

1 juin 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

INDÉCIS

Description du régime IPD

When our study is published as an article, the data on the individuals will be presented to researchers in tabular

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner